Tech+

UGAP is a new, non-invasive method for measuring a patient-specific, quantitative attenuation parameter that is well correlated to liver biopsy for discriminating hepatic steatosis among patients with CLD. The B-Mode image provides an anatomical guide while the attenuation and quality maps provide an attenuation quality guide. This combination provides extensive user assistance for proper placement of the UGAP measurement ROI. Lastly, automated algorithms optimize the results within the specified measurement ROI. As such, UGAP is an easy and fast tool that, in combination with 2D shear wave elastography, has the potential to aid in the initial diagnosis and follow-up care of CLD patients

Tissue stiffness is often related to underlying disease. For millennia, physicians have used palpation as a diagnostic tool to detect various ailments such as lesions, aneurysms, and inflammation. Stiff masses found during routine physical exams can be an early indication of disease, as in the cases of breast and prostate cancer. In some ailments, such as liver fibrosis, disease progression is marked by a gradual change in tissue stiffness. The ability to noninvasively measure tissue stiffness can therefore be a valuable tool in the diagnosis, staging, and management of disease.

GE Healthcare has designed its advanced cSound™ Architecture to put the latest ultrasound technology in the hands of clinicians. It combines the power of XDclear™ probes with a new cSound Imageformer to enable confident diagnoses, provide comprehensive tools, and support concise workflow.

There is a clinical need to visualize blood flow and vessel wall structures in the diagnosis of various vascular diseases. Also, it is believed that the vessel architecture can be an important indicator for lesion or disease assessment. Traditionally, Angiography, CT scans or MRI scans are used for this purpose. However, these modalities are more costly, access may be limited, and some use ionizing radiation and/or expensive contrast agents